Identification of Escherichia coli and Salmonella enterica organisms with reduced susceptibility to ceftriaxone from fecal samples of cows in dairy herds

American Journal of Veterinary Research

Volumn 70, Issue 3, 2009, Pages 389-393

  Heider, Luke C ^a   Funk, Julie A ^b   Hoet, Armando E ^a   Meiring, Richard W ^a   Gebreyes, Wondwossen A ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTIOFUR; CEFTRIAXONE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; CONTROLLED STUDY; DAIRY CATTLE; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; MILK PRODUCTION; NONHUMAN; PREVALENCE; SALMONELLA ENTERICA; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CEFTRIAXONE; CEPHALOSPORINS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FECES; FEMALE; SALMONELLA ENTERICA;

ANIMALIA; BOS; ESCHERICHIA COLI; SALMONELLA; SALMONELLA ENTERICA;

EID: 63249126904     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.70.3.389     Document Type: Article

References (21)

1. Gorbach SL. Antimicrobial use in animal feed - time to stop. N Engl J Med 2001;345:1202-1203.
2. McKellar QA. Antimicrobial resistance: a veterinary perspective. Antimicrobials are important for animal welfare but need to be used prudently. BMJ 1998;317:610-611.
3. Holmberg SD, Osterholm MT, Senger KA, et al. Drug-resistant S enterica from animals fed antimicrobials. N Engl J Med 1984;311:617-622.
4. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002;8:347-354.
5. Dunne EF, Fey PD, Kludt P, et al. Emergence of domestically acquired ceftriaxone-resistant S enterica infections associated with AmpC beta-lactamase. JAMA 2000;284:3151-3156.
6. Sawant AA, Sordillo LM, Jayarao BM. A survey on antibiotic usage in dairy herds in Pennsylvania. J Dairy Sci 2005;88:2991-2999.
7. Pol M, Ruegg PL. Treatment practices and quantification of antimicrobial drug usage in conventional and organic dairy farms in Wisconsin. J Dairy Sci 2007;90:249-261.
8. US FDA Center for Veterinary Medicine. Guidance for industry: evaluating the safety of antimicrobial new animal drugs with regard to their microbiological effects on bacteria of human health concern. Published guidance document No. 152. Rockville, Md: US FDA, 2003. Available at: www.fda.gov/cvm/Documents/fguide152.doc. Accessed Nov 5, 2005.
9. Anguto FJ, Johnson KR, Tauxe RV, et al. Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microb Drug Resist 2000;6:77-83.
10. USDA Agricultural Research Service. Bacterial epidemiology and antimicrobial resistance. National Antimicrobial Resistance Monitoring System: enteric bacteria. 2005 veterinary isolates final report. Washington, DC: USDA Agricultural Research Service, 2008. Available at: ars.usda.gov/Main/docs.htm?docid=16598. Accessed Feb 12, 2008.
11. CDC. National Antimicrobial Resistance Monitoting System: enteric bacteria. 2004 human isolates final report. Atlanta: US Department of Health and Human Services, 2007.
12. Carattoli A, Tosini F, Giles WP, et al. Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant S enterica strains isolated in the United States between 1996 and 1998. Antimicrob Agents Chemother 2002;46:1269-1272.
13. Winokur PL, Brueggemann A, DeSalvo DL, et al. Animal and human tnultidrug-resistant, cephalosporin-resistant S enterica isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrob Agents Chemother 2000;44:2777-2783.
14. Lowrance TC, Loneragan GH, Kunze DJ, et al. Changes in antimicrobial susceptibility in a population of Escherichia coli isolated from feedlot cattle administered ceftiofur crystalline-free acid. Am J Vet Res 2007;68:501-507.
15. Tragesser LA, Wittum TE, Funk JA, et al. Association between ceftiofur use and isolation of Escherichia coli with reduced susceptibility to ceftriaxone from fecal samples of dairy cows. Am J Vet Res 2006;67:1696-1700.
16. Fecteau ME, HouseJK, Kotarski SF, et al. Efficacy of ceftiofur for treatment of experimental salmonellosis in neonatal calves. Am J Vet Res 2003;64:918-925.
17. Donaldson SC, Straley BA, Hegde NV, et al. Molecular epidemiology of ceftiofur-resistant Escherichia coli isolates from dairy calves. Appl Environ Microbiol 2006;72:3940-3948.
18. Giles WP, Benson AK, Olson ME, et al. DNA sequence analysis of regions surrounding blaCMY-2 from multiple S enterica plasmid backbones. Antimicrob Agents Chemother 2004;48:2845-2852.
19. Winokur PL, Vonstein DL, Hoffman LJ, et al. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother 2001;45:2716-2722.
20. Huston CL, Wittum TE, Love BC, et al. Prevalence of fecal shedding of Salmonella spp in dairy herds. J Am Vet Med Assoc 2002;220:645-649.
21. Jiang X, Yang H, Dettman B, et al. Analysis of fecal microbial flora for antibiotic resistance in ceftiofur-treated calves. Foodborne Pathog Dis 2006;3:355-365.